Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
OPCH Option Care Health	$28.59 +2.4%	$29.77	$21.39 ▼ $35.53	$4.64B	0.79	1.86 million shs	2.26 million shs
RDNT RadNet	$71.29 +1.0%	$58.96	$45.00 ▼ $93.65	$5.48B	1.43	826,547 shs	503,843 shs
SHC Sotera Health	$16.50 +0.6%	$12.56	$9.53 ▼ $17.08	$4.69B	1.81	1.25 million shs	1.54 million shs
VRDN Viridian Therapeutics	$18.56 -0.5%	$16.73	$9.90 ▼ $27.20	$1.52B	0.42	897,671 shs	522,453 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
OPCH Option Care Health	-0.50%	-2.21%	-5.96%	-12.04%	-11.00%
RDNT RadNet	+1.41%	+3.89%	+22.92%	+27.64%	+8.32%
SHC Sotera Health	+0.06%	+1.49%	+33.33%	+34.43%	+4.99%
VRDN Viridian Therapeutics	+0.48%	+4.77%	+7.99%	+38.22%	+23.01%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
OPCH Option Care Health	4.8447 of 5 stars	3.4	3.0	4.3	4.2	3.3	1.9
RDNT RadNet	3.2523 of 5 stars	1.6	2.0	4.6	4.0	2.5	0.0
SHC Sotera Health	1.5379 of 5 stars	1.4	0.0	0.0	3.9	4.2	1.3
VRDN Viridian Therapeutics	1.9381 of 5 stars	4.5	0.0	0.0	2.9	0.0	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
OPCH Option Care Health	2.89	Moderate Buy	$35.75	25.04% Upside
RDNT RadNet	3.25	Buy	$71.60	0.43% Upside
SHC Sotera Health	2.80	Moderate Buy	$16.00	-3.03% Downside
VRDN Viridian Therapeutics	2.90	Moderate Buy	$37.78	103.54% Upside

Current Analyst Ratings Breakdown

Latest VRDN, RDNT, OPCH, and SHC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2025	VRDN Viridian Therapeutics	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$44.00
8/18/2025	RDNT RadNet	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/13/2025	RDNT RadNet	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$66.00 ➝ $75.00
8/11/2025	RDNT RadNet	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Overweight
8/8/2025	SHC Sotera Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
8/7/2025	VRDN Viridian Therapeutics	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$27.00 ➝ $30.00
8/7/2025	VRDN Viridian Therapeutics	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$45.00 ➝ $41.00
8/7/2025	VRDN Viridian Therapeutics	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$27.00 ➝ $26.00
8/7/2025	VRDN Viridian Therapeutics	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$28.00 ➝ $32.00
8/6/2025	VRDN Viridian Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$36.00 ➝ $34.00
7/31/2025	OPCH Option Care Health	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Outperform ➝ Market Outperform	$36.00 ➝ $38.00

(Data available from 8/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
OPCH Option Care Health	$5.00B	0.93	$1.68 per share	17.06	$8.38 per share	3.41
RDNT RadNet	$1.91B	2.87	$3.57 per share	19.98	$15.33 per share	4.65
SHC Sotera Health	$1.10B	4.26	$1.21 per share	13.64	$1.80 per share	9.17
VRDN Viridian Therapeutics	$300K	5,052.03	N/A	N/A	$4.00 per share	4.64

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
OPCH Option Care Health	$211.82M	$1.25	22.87	22.69	1.71	3.93%	17.53%	7.17%	10/29/2025 (Estimated)
RDNT RadNet	$2.79M	-$0.20	N/A	134.51	N/A	-0.78%	2.41%	0.82%	11/10/2025 (Estimated)
SHC Sotera Health	$44.34M	$0.08	206.28	23.57	N/A	2.14%	39.42%	5.66%	11/4/2025 (Estimated)
VRDN Viridian Therapeutics	-$269.95M	-$3.83	N/A	N/A	N/A	-112,806.88%	-78.95%	-49.91%	11/11/2025 (Estimated)

Latest VRDN, RDNT, OPCH, and SHC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2025	Q2 2025	RDNT RadNet	$0.17	$0.31	+$0.14	$0.43	$488.06 million	$498.23 million
8/8/2025	Q2 2025	SHC Sotera Health	$0.17	$0.20	+$0.03	$0.03	$275.81 million	$294.34 million
8/6/2025	Q2 2025	VRDN Viridian Therapeutics	-$1.00	-$1.00	N/A	-$1.00	$0.05 million	$0.08 million
7/30/2025	Q2 2025	OPCH Option Care Health	$0.40	$0.41	+$0.01	$0.31	$1.35 billion	$1.42 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
OPCH Option Care Health	N/A	N/A	N/A	N/A	N/A
RDNT RadNet	N/A	N/A	N/A	N/A	N/A
SHC Sotera Health	N/A	N/A	N/A	N/A	N/A
VRDN Viridian Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
OPCH Option Care Health	0.81	1.52	1.00
RDNT RadNet	0.91	2.00	2.00
SHC Sotera Health	4.49	2.47	2.23
VRDN Viridian Therapeutics	0.04	11.01	11.01

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
OPCH Option Care Health	98.05%
RDNT RadNet	77.90%
SHC Sotera Health	91.03%
VRDN Viridian Therapeutics	N/A

Insider Ownership

Company	Insider Ownership
OPCH Option Care Health	0.64%
RDNT RadNet	5.60%
SHC Sotera Health	55.12%
VRDN Viridian Therapeutics	0.65%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
OPCH Option Care Health	8,088	162.29 million	161.26 million	Optionable
RDNT RadNet	11,021	76.92 million	72.61 million	Optionable
SHC Sotera Health	3,000	284.05 million	127.48 million	Optionable
VRDN Viridian Therapeutics	50	81.66 million	81.13 million	Optionable

VRDN, RDNT, OPCH, and SHC Headlines

Recent News About These Companies

Viridian Therapeutics (NASDAQ:VRDN) Now Covered by Analysts at Jefferies Financial Group

August 27 at 10:05 AM | marketbeat.com

13,742 Shares in Viridian Therapeutics, Inc. $VRDN Purchased by EntryPoint Capital LLC

August 27 at 4:27 AM | marketbeat.com

Russell Investments Group Ltd. Sells 181,338 Shares of Viridian Therapeutics, Inc. $VRDN

August 27 at 3:46 AM | marketbeat.com

Viridian Therapeutics (NASDAQ:VRDN) Coverage Initiated at Jefferies Financial Group

August 27 at 2:45 AM | americanbankingnews.com

Algert Global LLC Sells 50,850 Shares of Viridian Therapeutics, Inc. $VRDN

August 26 at 4:05 AM | marketbeat.com

Viridian Therapeutics, Inc. $VRDN Stake Cut by Vanguard Group Inc.

August 26 at 3:20 AM | marketbeat.com

Viridian Therapeutics, Inc. $VRDN Shares Purchased by Candriam S.C.A.

August 24 at 6:17 AM | marketbeat.com

Viridian Therapeutics (NASDAQ:VRDN) & Y-mAbs Therapeutics (NASDAQ:YMAB) Critical Analysis

August 21, 2025 | americanbankingnews.com

HC Wainwright Issues Optimistic Estimate for VRDN Earnings

August 11, 2025 | marketbeat.com

Leerink Partnrs Issues Optimistic Outlook for VRDN Earnings

August 11, 2025 | marketbeat.com

Lifesci Capital Has Negative Estimate for VRDN Q3 Earnings

August 11, 2025 | marketbeat.com

Wedbush Research Analysts Boost Earnings Estimates for VRDN

August 11, 2025 | marketbeat.com

Wedbush Lowers Earnings Estimates for Viridian Therapeutics

August 9, 2025 | marketbeat.com

Viridian Therapeutics (NASDAQ:VRDN) Posts Earnings Results, Hits Expectations

August 9, 2025 | marketbeat.com

The Goldman Sachs Group Issues Positive Forecast for Viridian Therapeutics (NASDAQ:VRDN) Stock Price

August 8, 2025 | marketbeat.com

Viridian Therapeutics (NASDAQ:VRDN) Price Target Lowered to $41.00 at Royal Bank Of Canada

August 8, 2025 | marketbeat.com

Viridian Therapeutics (NASDAQ:VRDN) Price Target Lowered to $26.00 at Wells Fargo & Company

August 8, 2025 | marketbeat.com

Oppenheimer Increases Viridian Therapeutics (NASDAQ:VRDN) Price Target to $32.00

August 8, 2025 | marketbeat.com

Needham & Company LLC Cuts Viridian Therapeutics (NASDAQ:VRDN) Price Target to $34.00

August 7, 2025 | marketbeat.com

These Analysts Revise Their Forecasts On Viridian Therapeutics Following Q2 Results

August 7, 2025 | benzinga.com

Viridian partners with Kissei Pharmaceutical to develop thyroid eye disease therapies in Japan

August 7, 2025 | ophthalmologytimes.comO

New MarketBeat Followers Over Time

Media Sentiment Over Time

VRDN, RDNT, OPCH, and SHC Company Descriptions

Option Care Health NASDAQ:OPCH

$28.59 +0.67 (+2.40%)

Closing price 04:00 PM Eastern

Extended Trading

$27.90 -0.70 (-2.43%)

As of 05:43 PM Eastern

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

RadNet NASDAQ:RDNT

$71.29 +0.72 (+1.02%)

Closing price 04:00 PM Eastern

Extended Trading

$71.30 +0.00 (+0.01%)

As of 05:55 PM Eastern

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Sotera Health NASDAQ:SHC

$16.50 +0.10 (+0.61%)

Closing price 04:00 PM Eastern

Extended Trading

$16.51 +0.01 (+0.06%)

As of 04:10 PM Eastern

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Viridian Therapeutics NASDAQ:VRDN

$18.56 -0.10 (-0.54%)

Closing price 04:00 PM Eastern

Extended Trading

$18.55 -0.01 (-0.05%)

As of 05:51 PM Eastern

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time